AVIRAGEN THERAPEUTICS INC

Inactive Instrument

Transcripts Aviragen Therapeutics Inc Nasdaq

Equities

US0906941002

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Jul. 08	HilleVax to discontinue development of norovirus vaccine for infants; shares plummet	RE
Jun. 14	Sector Update: Health Care Stocks Lean Lower Pre-Bell Friday	MT

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Vaxart, Inc., Q1 2024 Earnings Call, May 13, 2024	May. 13
Transcript : Vaxart, Inc., 2023 Earnings Call, Mar 14, 2024	Mar. 14
Transcript : Vaxart, Inc., Q3 2023 Earnings Call, Nov 02, 2023	Nov. 02
Transcript : Vaxart, Inc. - Special Call	23-09-06
Transcript : Vaxart, Inc., Q2 2023 Earnings Call, Aug 03, 2023	23-08-03
Transcript : Vaxart, Inc. - Special Call	23-06-15
Transcript : Vaxart, Inc., Q1 2023 Earnings Call, May 04, 2023	23-05-04
Transcript : Vaxart, Inc. - Special Call	23-03-28
Transcript : Vaxart, Inc., 2022 Earnings Call, Mar 15, 2023	23-03-15
Transcript : Vaxart, Inc., Q3 2022 Earnings Call, Nov 08, 2022	22-11-08
Transcript : Vaxart, Inc. - Special Call	22-09-01
Transcript : Vaxart, Inc., Q2 2022 Earnings Call, Aug 08, 2022	22-08-08
Transcript : Vaxart, Inc. - Shareholder/Analyst Call	22-06-22
Transcript : Vaxart, Inc., 2021 Guidance/Update Call, Mar 02, 2021	21-03-02
Transcript : Vaxart, Inc. - Special Call	20-11-19
Transcript : Aviragen Therapeutics, Inc., Vaxart, Inc. - M&A Call	17-10-30

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Secure my Investments

fermer